532834 logo

Camlin Fine Sciences Limited Stock Price

BSE:532834 Community·₹37.5b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

532834 Share Price Performance

₹199.35
98.50 (97.67%)
32.4% undervalued intrinsic discount
₹295.00
Fair Value
₹199.35
98.50 (97.67%)
32.4% undervalued intrinsic discount
₹295.00
Fair Value
Price ₹199.35
AnalystConsensusTarget ₹295.00

532834 Community Narratives

AnalystConsensusTarget·
Fair Value ₹295 33.3% undervalued intrinsic discount

Tariff Benefits And Safety Trends Will Boost US And Europe

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative

Recent 532834 News & Updates

Tariff Benefits And Safety Trends Will Boost US And Europe

Key Takeaways Plant restarts and easing exceptional expenses are set to improve margins, with structural growth driven by global demand for compliant, high-quality food additives. Favorable trade barriers and China+1 supply diversification position Camlin Fine Sciences for market share gains, margin expansion, and reduced dependence on legacy products.

Camlin Fine Sciences Limited Key Details

₹17.1b

Revenue

₹9.2b

Cost of Revenue

₹7.9b

Gross Profit

₹7.1b

Other Expenses

₹824.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.39
Gross Margin
46.11%
Net Profit Margin
4.82%
Debt/Equity Ratio
77.9%

Camlin Fine Sciences Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Reasonable growth potential with mediocre balance sheet.

2 Risks
2 Rewards

About 532834

Founded
1931
Employees
661
CEO
Ashish Dandekar
WebsiteView website
www.camlinfs.com

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its prodycrts under the Xtendra, Nasure, Ezential, adorr, Dinamic, and Biosus brands. The company’s products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Indian Market Performance

  • 7 Days: 0.9%
  • 3 Months: 0.2%
  • 1 Year: -4.1%
  • Year to Date: 1.6%
Over the last 7 days, the market has remained flat, although notably the Information Technology sector gained 3.8% in that time. Unfortunately though, the market is down 4.1% over the past year. Earnings are forecast to grow by 16% annually. Market details ›